Tenfold enhancement in catalytic activity of platinum supported by carbon black for methanol oxidation was achieved by doping with single walled carbon nanotubes less than 2wt% of catalyst composite. The catalytic activity enhancement is attributed to the increase of catalyst utilization by improving interconnectivity among carbon blacks. This complies with the morphology, conductivity, and durability enhancement of the catalyst composites. Enhancement of the catalytic activity by doping a small fraction of carbon nanotubes into the catalyst composite is very promising as a highly efficient and cost-effective catalyst.

Silk fibroin biopolymer is anisotropically etched using oxygen and argon/oxygen plasma. At room temperature, silk removal rates are 0.25 µm min−1. Scanning electron micrographs show that silk fibroin is a heterogeneous material for which plasma etching reveals a silk backbone structure as the matrix is more quickly volatilized. A simple physical model of silk etching accurately predicts the etch rate without any fitting parameters. The model and experimental data show that atomic oxygen, in the absence of ion bombardment, only slowly etches silk (<0.017 µm min−1) and does not spontaneously etch silk fibroin backbone structures. Rather, the silk constituents must be removed by first covering the surface with adsorbed atomic oxygen which is then simultaneously desorbed through energetic ion bombardment. magnified image

Atomic layer deposition (ALD) technology is used to nanoengineer functional films inside the pores of microchannel plate (MCP) electron multipliers, enabling a novel MCP manufacturing technology that substantially improves performance and opens novel applications. The authors have developed custom tools and recipes for the growth of conformal films, with optimized conductance and secondary electron emission inside very long channels (∼6–20 μm diameter and &gt;600 μm length, with tens of millions of channels per single MCP) by ALD. The unique ability to tune the characteristics of these ALD films enables their optimization to applications where time-resolved single particle imaging can be performed in extreme conditions, such as high counting rates at cryogenic temperatures. Adhesion of the conductive and emissive nanofilms to the 20 μm pore MCP glass substrates and their mechanical stability over a very wide range of temperatures (10–700 K) were confirmed experimentally. Resistance of ALD MCPs was reproducible during multiple cool-down cycles with no film degradation observed. Optimizing resistance of novel MCPs for operation at cryogenic temperature should enable high count rate event detection at temperatures below 20 K.

Purpose: Our study aims to evaluate the effectiveness of intravenous erythropoietin (EPO) in patients with indirect traumatic optic neuropathy (TON), assess the side effects, and compare the visual function results among three groups of patients who had received different treatment options – EPO, steroids, and observation. Methods: Patients with indirect TON presenting to the neuro-ophthalmology clinic from August 2019 to March 2020, were assigned to three groups, with six patients in each group. In group 1, patients were recruited prospectively and received recombinant human erythropoietin, whereas, in groups 2 and 3, patients were recruited retrospectively and received intravenous methylprednisolone followed by oral steroids and multivitamins, respectively. Groups 1 and 2 included patients presenting within 2 weeks of trauma, whereas group 3 included those presenting beyond that. Best-corrected visual acuity, pupillary reaction, color vision, and visual fields following treatment were measured. Results: Initial visual acuity in the EPO group ranged from 20/80 to no perception of light (No PL). The mean initial BCVA (1.82 logMAR, standard deviation [SD] = 0.847) improved to 1.32, SD = 0.93 logMAR after treatment recorded at the third month ( P = 0.0375), with no significant adverse effects. The initial BCVA of group 2 ranged from 20/120 to No PL. The mean initial BCVA (1.95, SD = 0.77 logMAR) improved to 1.45 logMAR, SD = 0.97 after treatment ( P = 0.0435) but three patients had side effects of steroids. Initial visual acuity in Group 3 ranged from 20/40 to no PL. The mean initial BCVA (1.09 logMAR, SD = 1.10) worsened to 1.19 logMAR, SD = 1.06 after treatment after treatment ( P = 0.0193). The improvement in BCVA when compared between the three groups was not significant. Conclusion: Both erythropoietin and steroids are effective in the management of traumatic optic neuropathy. However, erythropoietin shows lesser or no side effects when compared to steroids.